1. Home
  2. UEIC vs QTTB Comparison

UEIC vs QTTB Comparison

Compare UEIC & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Electronics Inc.

UEIC

Universal Electronics Inc.

HOLD

Current Price

$4.08

Market Cap

48.3M

ML Signal

HOLD

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$4.10

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UEIC
QTTB
Founded
1986
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.3M
44.3M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
UEIC
QTTB
Price
$4.08
$4.10
Analyst Decision
Buy
Hold
Analyst Count
2
3
Target Price
$9.25
$7.33
AVG Volume (30 Days)
85.3K
160.1K
Earning Date
02-19-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$390,997,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.35
N/A
52 Week Low
$2.69
$1.35
52 Week High
$11.02
$6.37

Technical Indicators

Market Signals
Indicator
UEIC
QTTB
Relative Strength Index (RSI) 70.77 70.08
Support Level $3.81 $3.35
Resistance Level $4.07 $4.19
Average True Range (ATR) 0.16 0.30
MACD 0.05 0.06
Stochastic Oscillator 91.30 91.00

Price Performance

Historical Comparison
UEIC
QTTB

About UEIC Universal Electronics Inc.

Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: